Arbutus Biopharma (ABUS) Capital Expenditures (2013 - 2024)
Arbutus Biopharma (ABUS) posted Capital Expenditures of $86,000 for Q4 2024.
Powered by 
Analysis
Arbutus Biopharma (ABUS) Capital Expenditures (2013 - 2024) Analysis & Trends
For FY2024, Arbutus Biopharma's Capital Expenditures came in at $182,000, down 81.9% from FY2023.
- Annual Capital Expenditures shows a five-year compound annual growth rate of -20.9% (FY2019 to FY2024).
- In prior years, Arbutus Biopharma's Capital Expenditures was $1.01 million in FY2023 (+96.9%), $512,000 in FY2022 (-36.7%), $809,000 in FY2021 (+253.3%) and $229,000 in FY2020 (-61.1%).
- Quarterly Capital Expenditures has run from a low of $1,000 in Q2 2024 to a high of $859,000 in Q2 2023 over five years.
- On a year-over-year basis, Capital Expenditures increased in two of the last five quarters, with growth averaging 35.5%.
- The strongest year-over-year quarter for Capital Expenditures in the past five years was Q2 2021, with growth of 857.6%; the weakest was Q2 2024, with a decline of 99.9%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Arbutus Biopharma | 960.50 Mn | 587.48 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 86,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Mar 31, 2024 | 95,000.00 |
| Sep 30, 2023 | 32,000.00 |
| Jun 30, 2023 | 859,000.00 |
| Mar 31, 2023 | 117,000.00 |
| Dec 31, 2022 | 134,000.00 |
| Sep 30, 2022 | 91,000.00 |
| Jun 30, 2022 | 212,000.00 |
| Mar 31, 2022 | 75,000.00 |
| Dec 31, 2021 | 58,000.00 |
| Sep 30, 2021 | 20,000.00 |
| Jun 30, 2021 | 632,000.00 |
| Mar 31, 2021 | 99,000.00 |
| Dec 31, 2020 | 152,000.00 |
| Sep 30, 2020 | 11,000.00 |
| Jun 30, 2020 | 66,000.00 |
| Dec 31, 2019 | 63,000.00 |
| Sep 30, 2019 | 255,000.00 |
| Jun 30, 2019 | 240,000.00 |
API Access
Arbutus Biopharma Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ABUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "ABUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ABUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();